4(i). immunization
TRANSCRIPT
-
8/9/2019 4(i). Immunization
1/51
ImmunizationMartira MaddeppungengChild Health Department
Medical Faculty Hasanuddin University
Dr Wahidin Sudirohusodo Hospital
-
8/9/2019 4(i). Immunization
2/51
The hepatitis Bvirus
Bordetella pertussis
The measles virus
Clostridium tetani Corynebacterium
diphtheriae
Introduction
-
8/9/2019 4(i). Immunization
3/51
ImmunizationGive protection on specific infection disease!accine"preventa#le disease$
%he rights of the child&arents' health employer(s guaranteed thatimmunizations are availa#le for all children
-
8/9/2019 4(i). Immunization
4/51
-
8/9/2019 4(i). Immunization
5/51
ImmunizationPassive
Active
-
8/9/2019 4(i). Immunization
6/51
&assive ImmunizationPassive immunity : get readymade antibodiesMaternal antibodies are transferred to the fetus
through the placenta (3rd trimester !"ample: tetanus to"oid administered topregnant mother #ill decrease neonatal tetanus
-
8/9/2019 4(i). Immunization
7/51
&assive Immunization$uman immunoglobulin to protect from measles%pecific immunoglobulin to protect from
tetanus& diphtheria& hepatitis B& rabies' ( M)& varicella
-
8/9/2019 4(i). Immunization
8/51
)ctive ImmunizationAdministration of antigenic material to stimulateimmune response li*e natural infection
+ong life immunological memory+ong life protection to infection disease
-
8/9/2019 4(i). Immunization
9/51
)ctive Immunization,sed:
-hole organism (live or *illedomponent organism (sub unit vaccine&
polisaccharide vaccineModification of organism product
(to"oid vaccine
Manufactur of organism component(recombinant vaccine
-
8/9/2019 4(i). Immunization
10/51
Ideal !accine.ive protection on infection disease.ive long/life immunity
0o side effect%ingle dosean be given by combination
-
8/9/2019 4(i). Immunization
11/51
Ideal !accine *$!asy administration& no pain%table in many conditions
an be *ept for long time duration1easonably priced
-
8/9/2019 4(i). Immunization
12/51
Bacteria
Virus Live : BCG
Inactive: diphteria,pertussis, tetanus,cholera,pneumococcu
s, meningococcus,Hib, Typhoid
Live : OV , measles, varicella, parotitis,rubella, yello! "ever
Inactive : in#uen$a,IV , rabies, Hepatitis%, Hepatitis B
-
8/9/2019 4(i). Immunization
13/51
&&IProgram Pengembangan Imunisasi :
B .
$epatitis B2TPPolioMeasles
-
8/9/2019 4(i). Immunization
14/51
Recommended Immunization Schedule
(IDAI 2006)
& )dminister * doses separated #y + ,ee-s or longer$ to children ≤ . years ,ho are receiving influenzavaccine for the first time or ,ho ,ere vaccinated for the first time last season #ut only received one dose
-
8/9/2019 4(i). Immunization
15/51
'ecommended Immuni$ation (chedule
)*+*
-
8/9/2019 4(i). Immunization
16/51
BCG
/ Optimal administered age ) - months/ I" age . - months : /antou0 1 tuber2ulin test/ I" tuber2ulin pra BCG can not be done, BCG can beadministered,
must be observed 3 days/ I" accelerated local reaction (+) , need "urtherevaluation
4TB diagnostic5
-
8/9/2019 4(i). Immunization
17/51
Hepatitis B
%dministered 6rst HepB !ithin +) hours o"birth
-
8/9/2019 4(i). Immunization
18/51
7T 8 olio
9 O V administered !hen 6rst visit/ Baby that !as born in hospital : administered O V!hen baby
!ill discharge "rom hospital to prevent viraltransmission to
others baby/ Continue administer !ith OPV or IPV/ 7T vaccine "or children . ; !ee2s/ Can be administered 7T! or 7Ta or combination!ith Hep B
or Hib/ 'epeat dose 7T should be administered at age +<
-
8/9/2019 4(i). Immunization
19/51
/easles
%dminister the second dose o" //' at
age = 3 yearsBI%( rogram : proposed and updated!ith recommended immuni$ationschedule by health department
-
8/9/2019 4(i). Immunization
20/51
0CG
-
8/9/2019 4(i). Immunization
21/51
0CGBaby 3 months2ose : 4&45 ml I 6 I2
1ight deltoidIf age 7 3 months : Mantou" 6 tuber*ulin test+evel of protection only 89 (-$; 54/
-
8/9/2019 4(i). Immunization
22/51
-
8/9/2019 4(i). Immunization
23/51
2I&I 3 !)452e6adian I-utan &asca Imunisasi Vaccine AdverseEvents Report)0CG Superficial ulcus 7 ,ee-s crusta scar +"8 ,ee-s
9imphadenitis : 0CG itisDisseminated 0CG"itis ; severe immunodeficiency
-
8/9/2019 4(i). Immunization
24/51
D%&
-
8/9/2019 4(i). Immunization
25/51
D%&Prevent diphteria& tetanus& pertussisontain: 2ipteria to"oid&
Tetanus to"oid&Pertussis vaccine : / whole cell / acellular
-
8/9/2019 4(i). Immunization
26/51
-
8/9/2019 4(i). Immunization
27/51
-
8/9/2019 4(i). Immunization
28/51
-
8/9/2019 4(i). Immunization
29/51
D%&Basic ; 3 times since age 9 months interval +"8 ,ee-s1epeat :
" ?=/98 months 5/< years
?9 years (BIA% program: 2T $
-
8/9/2019 4(i). Immunization
30/51
Contraindication D%&
Absolute:is reaction
*=!ncephalopathy )cutely severe neurologicaldisease ,ith long convulsion and?or decrease ofconsciousness and?or focal neurological disorder$
-
8/9/2019 4(i). Immunization
31/51
• Specific precaution :ia
*=Hypotonic hyporesponsiveness in+8 hours
7= &ersistent crying @ 7 hours
+= History of convulsion 7 days afterimmunization
Contraindication D%&
-
8/9/2019 4(i). Immunization
32/51
'ecommended D%&D%& < ; *"+ monthsD%& * ; 7"A months
D%& 7 ; +"B monthsD%& + ; < " * yearsD%& A ; A yearsD% B ;
-
8/9/2019 4(i). Immunization
33/51
Table 2. Approximate rates of adverse event occurring within 48 hours DTP vaccination
Event re!uenc"
#ocal
redness, swelling, pain 1 in 2-3 doses
$ild%moderate s"stemic
fever, drowsiness, fretfulness 1 in 2-3 doses
vomiting, anorexia 1 in 5-15 doses
$ore serious s"stemic
persistent crying, fever 1 in 100-300 doses
collapse, convulsions 1 in 1750 doses
acute encephalopathy 1 in 100,000 doses
permanent neurological deficit 1 in 300,000 doses
-
8/9/2019 4(i). Immunization
34/51
&olio
-
8/9/2019 4(i). Immunization
35/51
&olioPrevent : poliomyelitis Flaccid paralysis, pain at bac* and e"tremity
Polio vaccine :+ive (%abin : oral @illed (%al* : parenteral
-
8/9/2019 4(i). Immunization
36/51
-
8/9/2019 4(i). Immunization
37/51
Contraindication&olio : &!
%emperature @ 78'AE CCorticosteroid' radiation
MalignancyHI! infection or familySi#lings ,ith immunocompromised child
-
8/9/2019 4(i). Immunization
38/51
'ecommended i &olio&olio < ; #ornD&% < &olio * ; *"+ months
D&% * &olio 7 ; 7"A monthsD&% 7 &olio + ; +"B monthsD&% + &olio A ; < " * yearsD&% A &olio B ; A years
D% B ;
-
8/9/2019 4(i). Immunization
39/51
Hepatitis 0
-
8/9/2019 4(i). Immunization
40/51
Hepatitis 0Prevent hepatitis B
$epatitis B vaccine:2erivat plasma vaccine1ecombinant vaccine
-
8/9/2019 4(i). Immunization
41/51
-
8/9/2019 4(i). Immunization
42/51
Hepatitis 0$B/? administered recom#inant vaccine H0 < mcgintramuscular' ,ithin
-
8/9/2019 4(i). Immunization
43/51
Contraindication Hepatitis 01o contraindication' e>cept pregnant mother
-
8/9/2019 4(i). Immunization
44/51
Measles
-
8/9/2019 4(i). Immunization
45/51
MeaslesLive attenuated virusAge months
2ose 4'5 ml %ontraindication : $igh fever& immunosupression&immunoglobulin or given blood component1epeat : age 5/< years
-
8/9/2019 4(i). Immunization
46/51
-
8/9/2019 4(i). Immunization
47/51
Measles " !)45ever 5/?5 on A"B th day after immunization' for *days1ash 5 & on "< th day' for *"+ days4ncephalitis and encephalopathy 3 < ; < miiliondosis ,ithin 7 days after immunization
-
8/9/2019 4(i). Immunization
48/51
1on &&I !accine$ibMM1Typhoid$epatitis A)aricellaInfluenza
Pneumococcus
-
8/9/2019 4(i). Immunization
49/51
-
8/9/2019 4(i). Immunization
50/51
-
8/9/2019 4(i). Immunization
51/51